TY - JOUR
T1 - Carbon ion radiotherapy for basal cell adenocarcinoma of the head and neck
T2 - Preliminary report of six cases and review of the literature
AU - Jingu, Keiichi
AU - Hasegawa, Azusa
AU - Mizo, Jun Etsu
AU - Bessho, Hiroki
AU - Morikawa, Takamichi
AU - Tsuji, Hiroshi
AU - Tsujii, Hirohiko
AU - Kamada, Tadashi
N1 - Copyright:
Copyright 2010 Elsevier B.V., All rights reserved.
PY - 2010/10/4
Y1 - 2010/10/4
N2 - Background: Basal cell adenocarcinoma accounts for approximately 1.6% of all salivary gland neoplasms. In this report, we describe our experiences of treatment for BCAC with carbon ion radiotherapy in our institution.Methods: Case records of 6 patients with diagnosis of basal cell adenocarcinoma of the head and neck, who were treated by carbon ion radiotherapy with 64.0 GyE/16 fractions in our institution, were retrospectively reviewed.Results: In a mean follow-up period of 32.1 months (14.0-51.3 months), overall survival and local control rates of 100% were achieved. Only one grade 4 (CTCAE v3.0) late complication occurred. There was no other grade 3 or higher toxicity.Conclusions: Carbon ion radiotherapy should be considered as an appropriate curative approach for treatment of basal cell adenocarcinoma in certain cases, particularly in cases of unresectable disease and postoperative gross residual or recurrent disease.
AB - Background: Basal cell adenocarcinoma accounts for approximately 1.6% of all salivary gland neoplasms. In this report, we describe our experiences of treatment for BCAC with carbon ion radiotherapy in our institution.Methods: Case records of 6 patients with diagnosis of basal cell adenocarcinoma of the head and neck, who were treated by carbon ion radiotherapy with 64.0 GyE/16 fractions in our institution, were retrospectively reviewed.Results: In a mean follow-up period of 32.1 months (14.0-51.3 months), overall survival and local control rates of 100% were achieved. Only one grade 4 (CTCAE v3.0) late complication occurred. There was no other grade 3 or higher toxicity.Conclusions: Carbon ion radiotherapy should be considered as an appropriate curative approach for treatment of basal cell adenocarcinoma in certain cases, particularly in cases of unresectable disease and postoperative gross residual or recurrent disease.
UR - http://www.scopus.com/inward/record.url?scp=77957269349&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77957269349&partnerID=8YFLogxK
U2 - 10.1186/1748-717X-5-89
DO - 10.1186/1748-717X-5-89
M3 - Article
C2 - 20920325
AN - SCOPUS:77957269349
VL - 5
JO - Radiation Oncology
JF - Radiation Oncology
SN - 1748-717X
IS - 1
M1 - 89
ER -